Digital Marketing 101: How to Advertise Your Pharmacy
Pharmacies that haven’t added digital marketing and advertising to their mix are missing the target.
Lumateprone Tosylate Approved for Schizophrenia
The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.
FDA Issues Warning for Chlorine Dioxide Products Claiming to Treat COVID-19
Officials with the FDA issued a warning letter to a company marketing fraudulent and dangerous chlorine dioxide products for the prevention and treatment of novel coronavirus disease 2019.
FDA Approves First Generic of Albuterol Sulfate Inhaler
The announcement follows recent albuterol shortages reports due to the COVID-19 pandemic.
New Diabetes Medications, Technologies You Should Know
Pharmacists can play an integral role in managing patients with diabetes.
Study Investigates COVID-19 Mortality, Early Indicators of Poor Prognosis
As COVID-19 continues to spread, and the death toll rises, experts aim to better understand the clinical features of the disease and factors for increased mortality.
How to Attract Millennial Customers
Pharmacists weigh in on how to bring this generation to the pharmacy.
Autoimmunity Prevalence Increasing in the United States
Autoimmunity and certain autoimmune diseases have been increasing in prevalence in the United States.
DEA Deschedules Antiepileptic CBD Oral Solution Epidiolex
Cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is no longer considered a controlled substance.
Study: Actual Number of COVID-19 Cases Vastly Underestimated
According to the findings, on average, only 6% of actual SARS-CoV-2 infections have been detected worldwide, meaning that the vast majority of infections have gone undetected.
First Successful Medical Drone Delivery Supplies ‘Full Circle’ Diabetes Care
The successful maiden flight of an autonomous drone delivering insulin shows the potential for drone use in the delivery of lifesaving medications and supplies during disasters.
Communicating with Patients in the Time of COVID-19
Pharmacies, just as expected, have showed up in meaningful ways to support their communities.
Incyte, Novartis Plan Phase 3 Trial for Ruxolitinib in COVID-19
The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.
FDA to Accelerate Development of Blood-Related Therapies for COVID-19
The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.
FDA OKs Ixekizumab for Pediatric Patients with Plaque Psoriasis
Officials with the FDA have granted approval to ixekizumab (Taltz, Eli Lilly) injection, 80 mg/mL for the treatment of pediatric patients with moderate-to-severe plaque psoriasis.
FDA Approves Luspatercept-aamt for Anemia in Lower-Risk Myelodysplastic Syndromes
Officials with the FDA have approved luspatercept-aamt (Reblozyl, Bristol Myers Squibb and Acceleron Pharma) for the treatment of anemia in adults with lower-risk myelodysplastic syndromes.
Many Hospital Pharmacists Report Moderate-to-Major Disruptions in Mask Supply
Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.
Coronavirus News Roundup: FDA Emergency Use Authorizations, Vaccine Candidate, and Virtual Blood Drives
Here's a roundup of the latest coronavirus-related news.
FDA OKs Treatment for Hemophilia A or B with Inhibitors
Coagulation factor VIIa (recombinant)-jncw (Sevenfact, LBF) contains an active ingredient from a genetically engineered animal.
Studies Examine Association Between Opioid Prescriptions and Obesity
Obesity may contribute to incident long-term prescription opioid use due to underlying pain conditions.
Please Donate Blood!
During times like these, we must come together and help those in need.
Rimegepant Demonstrates Efficacy in Prevention of Migraine
Rimegepant (Nurtec ODT, Biohaven Pharmaceuticals) reduced monthly migraine days in patients with episode and chronic migraine in a clinical trial.
Clinical Trial Tests Efficacy of Short-Acting GLP-1 Receptor Agonist in Type 1 Diabetes
A clinical trial funded by AstraZeneca evaluated the use of short-acting GLP-1 receptor agonists as an add-on treatment to insulin therapy in type 1 diabetes.
FDA Requests Removal of All Ranitidine from Market
Officials with the FDA have requested that manufacturers of all ranitidine (Zantac) drugs, both prescription and over-the-counter, remove their products from the market.
Bempedoic Acid Tablets Now Available in Pharmacies
Bempedoic acid (Nexletol, Esperion), an oral, once-daily, non-statin low-density lipoprotein-cholesterol lowering medicine, is now available in US pharmacies.
Community Pharmacies Project Successful in Increasing Adult Vaccinations
The purpose of the project was to increase the number of influenza, pertussis, pneumococcal, and herpes zoster vaccines provided to adults.
RxSafe LLC Launches ViralGuardRx COVID-19 Protection
As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances.
What Is Disseminated Zoster?
Less common but more communicable than localized zoster
Ticagrelor Monotherapy Shows Cardiovascular Benefit in Patients with Diabetes
Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.
How Are Pharmacies Protecting Staff from COVID-19?
Concerns about adequate protection from COVID-19 have led to several efforts from chain pharmacies to keep pharmacy staff and employees safe.